Neurological disorder therapeutic - Lipocine
Alternative Names: Neuroactive-steroid-lipocineLatest Information Update: 09 May 2023
Price :
$50 *
At a glance
- Originator Lipocine
- Class Steroids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Neurological disorders
Most Recent Events
- 28 Mar 2023 Neurological disorder therapeutic - Lipocine is available for licensing as of 28 Mar 2023. https://www.lipocine.com/partnering/
- 28 Mar 2023 Lipocine has patent protection for proprietary Lip'ral drug delivery technology (Lipocine website, March 2023)
- 28 Mar 2023 Preclinical trials in Neurological disorders in USA (PO) (Lipocine pipeline, March 2023)